How much funding has Variant Bio raised?

Variant Bio has raised $171.0M in total funding, most recently a Corporate Round.

Who are Variant Bio's investors?

Variant Bio's investors include Novo Nordisk, Lux Capital, SoftBank, General Catalyst.

When was Variant Bio founded?

Variant Bio was founded in 2018.

Where is Variant Bio headquartered?

Variant Bio is headquartered in Seattle, Washington, United States.

What industry is Variant Bio in?

Variant Bio operates in Life Sciences.

How many employees does Variant Bio have?

Variant Bio has 11-50 employees.

Variant Bio

Exceptional traits among us.

Seattle, United States · Founded 2018 · $171.0M raised

Life Sciences

Headquarters: Seattle, Washington
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: variantbio.com
Total Funding: $171.0M
Last Round: $50.0M Corporate RoundJan 2025
Rounds: 3

About

Variant Bio studies genetic variants of health outliers to identify drug targets. Founded 2018 in Seattle. Partnership with Novo Nordisk worth up to $50M.

Summary

Variant Bio is a Life Sciences company based in Seattle, United States, founded in 2018. It has raised $171.0M in total across 3 rounds, most recently a $50.0M Corporate Round round in Jan 2025. Investors include Novo Nordisk, Lux Capital and SoftBank.

LinkedIn X (Twitter)